FDC shares gain 5.96% as Q2 net profit surges 73% YoY to Rs49 Cr; board approves Rs120 Cr share buyback at Rs500 apiece
India, Oct. 28 -- The company is an Indian pharmaceutical company engaged in the development, manufacturing and marketing of pharmaceutical formulations and healthcare products. Its portfolio includes products across domestic and international markets, with brands such as Electral, Enerzal and Zifi. The company operates in domestic and international formulations, making product demand, distribution reach, export growth and operating margins important factors influencing its financial performance
The Nifty 50 is trading at 22,657.2, down by 0.41%, while the Sensex fell to 73,176.40, down by 0.57% on Wednesday. The shares of FDC are currently trading at Rs. 374.90, up by 5.96%. The company has a market capitalisation of Rs. 6,103.75 crore...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.